The outlook for the stock of Sun Pharmaceutical Industries is bullish. The stock surged 6.9 per cent on Wednesday and has closed on a strong note. This strong rally has taken the stock well above the 200-day moving average at ₹561 and a trendline resistance at ₹564. These two levels may now serve as a good short-term support. Additionally, the decisive break above ₹564 confirms an inverted head ...